Volume 68, Issue 5, Pages (November 2005)

Slides:



Advertisements
Similar presentations
Human tissue kallikrein gene delivery attenuates hypertension, renal injury, and cardiac remodeling in chronic renal failure  William C. Wolf, Hideaki.
Advertisements

Aprotinin improves kidney function and decreases tubular cell apoptosis and proapoptotic signaling after renal ischemia-reperfusion  Ajay Kher, MD, Kirstan.
Volume 63, Issue 2, Pages (February 2003)
Volume 59, Issue 6, Pages (June 2001)
Volume 68, Issue 4, Pages (October 2005)
The roles of IGF-I and IGFBP-3 in the regulation of proximal tubule, and renal cell carcinoma cell proliferation  Catherine W. Cheung, David A. Vesey,
Volume 73, Issue 11, Pages (June 2008)
Volume 78, Issue 3, Pages (August 2010)
Volume 66, Issue 4, Pages (October 2004)
Volume 88, Issue 3, Pages (September 2015)
Exogenous surfactant attenuation of ischemia–reperfusion injury in the lung through alteration of inflammatory and apoptotic factors  Bart P. van Putte,
Autocrine and paracrine functions of vascular endothelial growth factor (VEGF) in renal tubular epithelial cells  Guillermo Villegas, Bäerbel Lange-Sperandio,
Membranous nephropathy: When and how to treat
Volume 66, Issue 3, Pages (September 2004)
Volume 67, Issue 5, Pages (May 2005)
Characterization of proteinuria and tubular protein uptake in a new model of oral L-lysine administration in rats  K. Thelle, E.I. Christensen, H. Vorum,
Volume 68, Issue 2, Pages (August 2005)
Volume 60, Issue 2, Pages (August 2001)
Volume 68, Issue 5, Pages (November 2005)
Treatment of early mixed cellular and humoral renal allograft rejection with tacrolimus and mycophenolate mofetil  Q. Sun, Z-H. Liu, Z. Cheng, J. Chen,
Volume 62, Issue 1, Pages (July 2002)
Mast cells decrease renal fibrosis in unilateral ureteral obstruction
Volume 68, Issue 6, Pages (December 2005)
Volume 63, Issue 4, Pages (April 2003)
Volume 68, Issue 1, Pages (July 2005)
Volume 73, Issue 4, Pages (February 2008)
Volume 63, Issue 4, Pages (April 2003)
Evidence for low-density lipoprotein–induced expression of connective tissue growth factor in mesangial cells  Mimi Sohn, Yan Tan, Richard L. Klein, Ayad.
Endogenous hepatocyte growth factor ameliorates chronic renal injury by activating matrix degradation pathways  Youhua Liu, Krupa Rajur, Evelyn Tolbert,
Autophagy in proximal tubules protects against acute kidney injury
Volume 56, Issue 3, Pages (September 1999)
Volume 22, Issue 10, Pages (October 2014)
Volume 58, Issue 1, Pages (July 2000)
Volume 54, Issue 5, Pages (November 1998)
Volume 68, Issue 4, Pages (October 2005)
Volume 60, Issue 5, Pages (November 2001)
Volume 62, Issue 4, Pages (October 2002)
Volume 63, Issue 4, Pages (April 2003)
Gene transfer of truncated IκBα prevents tubulointerstitial injury
Ischemic and non-ischemic acute kidney injury cause hepatic damage
The roles of IGF-I and IGFBP-3 in the regulation of proximal tubule, and renal cell carcinoma cell proliferation  Catherine W. Cheung, David A. Vesey,
Volume 77, Issue 4, Pages (February 2010)
Volume 63, Issue 6, Pages (June 2003)
Human tissue kallikrein gene delivery attenuates hypertension, renal injury, and cardiac remodeling in chronic renal failure  William C. Wolf, Hideaki.
Volume 61, Issue 6, Pages (June 2002)
Volume 63, Issue 2, Pages (February 2003)
Volume 64, Issue 3, Pages (September 2003)
Wei-Zhong Ying, Pei-Xuan Wang, Paul W. Sanders  Kidney International 
Caspase-3 and apoptosis in experimental chronic renal scarring
Volume 68, Issue 6, Pages (December 2005)
C5b-9 regulates peritubular myofibroblast accumulation in experimental focal segmental glomerulosclerosis  Gopala K. Rangan, Jeffrey W. Pippin, William.
Pivotal role of xanthine oxidase in the initiation of tubulointerstitial renal injury in rats with hyperlipidemia  W. Gwinner, H. Scheuer, H. Haller,
Volume 82, Issue 3, Pages (August 2012)
Volume 70, Issue 8, Pages (October 2006)
M.-J. Wu, M.-C. Wen, Y.-T. Chiu, Y.-Y. Chiou, K.-H. Shu, M.-J. Tang 
Volume 67, Issue 6, Pages (June 2005)
Volume 55, Issue 6, Pages (June 1999)
Volume 60, Issue 5, Pages (November 2001)
Volume 64, Issue 3, Pages (September 2003)
Laminin-8/9 is synthesized by rat glomerular mesangial cells and is required for PDGF- induced mesangial cell migration  Kim Hansen, Christine K. Abrass 
Volume 56, Issue 6, Pages (December 1999)
Volume 80, Issue 2, Pages (July 2011)
Volume 58, Issue 3, Pages (September 2000)
Volume 72, Issue 11, Pages (December 2007)
Volume 58, Issue 6, Pages (December 2000)
Volume 55, Issue 4, Pages (April 1999)
Differential effects of simvastatin on mesangial cells
Volume 70, Issue 1, Pages (July 2006)
Volume 68, Issue 5, Pages (November 2005)
Volume 75, Issue 2, Pages (January 2009)
Presentation transcript:

Volume 68, Issue 5, Pages 2050-2067 (November 2005) Inflammation and caspase activation in long-term renal ischemia/reperfusion injury and immunosuppression in rats  B.I.N. Yang, Sunjay Jain, Izabella Z.A. Pawluczyk, Shehla Imtiaz, L.E.E. Bowley, Shairbanu Y. Ashra, Michael L. Nicholson  Kidney International  Volume 68, Issue 5, Pages 2050-2067 (November 2005) DOI: 10.1111/j.1523-1755.2005.00662.x Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 1 Endothelin-1 (ED-1+) cells in different compartments of kidneys and staining profiles in various experimental groups. ED-1+ cells were detected in the glomerulus (A), peri glomerular areas, peritubular areas, expanded interstitial areas (B), and tubular lumen (C, arrows) at ×400 magnification. ED-1+ cells were scattered in the controls [control (sham-operated) and unilateral nephrectomy (UN)]; (D) and dramatically increased in ischemia/reperfusion (I/R) kidneys (E), and were further increased by cyclosporine A (CsA) treatment (F), mainly in interstitial areas, but decreased by tacrolimus (Tac) (G), rapamycin (Rap) (H), and mycophenolate mofetil (MMF) (I) treatment at ×200 magnification. Histogram (J) shows the ED-1+ staining as a percentage of the whole area in the kidneys of various groups using computer aided semiquantitative analysis. Data represents mean ± SEM (N = 4 to 6). *P < 0.05; **P < 0.01. Kidney International 2005 68, 2050-2067DOI: (10.1111/j.1523-1755.2005.00662.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 2 Expression of interleukin(IL)-1β protein detected by Western blot analysis. Sample immunoblots showed 35 kD precursor and 17 kD active subunit of IL-1β. A 42 kD band of β-actin was detected to show the loading of samples in each lane. Histogram data represent the result of volume density analysis 35 kD (A) and 17 kD (B) IL-1β using β-actin to correct for loading. Data represent the mean percentage change in volume density compared to the average control value (mean ± SEM) (N = 4 to 6). *P < 0.05; **P < 0.01. Abbreviations are: control, sham-operated; UN, unilateral nephrectomy; I/R, ischemia/reperfusion; CsA, cyclosporine A; Tac, tacrolimus; Rap, rapamycin; MMF, mycophenolate mofetil. Kidney International 2005 68, 2050-2067DOI: (10.1111/j.1523-1755.2005.00662.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 3 Caspase-1 Western blots revealed 45 kD precursor and 20 kD active subunit. A 42 kD band of β-actin was detected to show the loading of samples in each lane. Histogram data represent the result of volume density analysis of 45 kD (A) and 20 kD (B) caspase-1 using β-actin to correct for loading, and the detection of caspase-1 activity (C). Data represent the mean percentage change in volume density compared to the average control value (mean ± SEM) (N = 4 to 6). *P < 0.05; **P < 0.01. Abbreviations are: Control, sham-operated; UN, unilateral nephrectomy; I/R, ischemia/reperfusion; CsA, cyclosporine A; Tac, tacrolimus; Rap, rapamycin; MMF, mycophenolate mofetil. Kidney International 2005 68, 2050-2067DOI: (10.1111/j.1523-1755.2005.00662.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 4 Expression of caspase-3 protein detected by Western blot analysis. Immunoblots showed a 32 kD band, representing the precursor of caspase-3; a 29 kD band, representing processing intermediate of caspase-3; 17 kD and 24 kD bands, representing the caspase-3 active subunits. The expression of 42 kD β-actin demonstrates the equal loading of samples in each lane. Histogram data represent the result of volume density analysis 32 kD (A), 24 kD (B), and 17 kD (C) caspase-3 using β-actin to correct for loading. Data represent the mean percentage change in volume density compared to the average control value (mean ± SEM) (N = 4 to 6). *P < 0.05; **P < 0.01. Abbreviations are: control, sham-operated; UN, unilateral nephrectomy; I/R, ischemia/reperfusion; CsA, cyclosporine A; Tac, tacrolimus; Rap, rapamycin; MMF, mycophenolate mofetil. Kidney International 2005 68, 2050-2067DOI: (10.1111/j.1523-1755.2005.00662.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 5 Caspase-3 activity in kidney tissues assayed by the fluorometric substrate cleavage. This measurement was repeated three times and data represents mean ± SEM (N = 4 to 6). *P < 0.05; **P < 0.01. Abbreviations are: control, sham-operated; UN, unilateral nephrectomy; I/R, ischeemia/reperfusion; CsA, cyclosporine A; Tac, tacrolimus; Rap, rapamycin; MMF, mycophenolate mofetil. Kidney International 2005 68, 2050-2067DOI: (10.1111/j.1523-1755.2005.00662.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 6 Caspase-3 activity in electroeluted homogenate samples. Caspase-3 activity was highest in chamber 6 and some weaker activity was detected in chamber 10. 100 μg protein of kidney homogenate from rat number 6 of the cyclosporine A (CsA) group and rat number 4 of the mycophenolate mofetil (MMF) group, and 44ng or 11ng protein of pure caspase-3 enzyme were used as positive controls (A). Electroeluted samples were resolved by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and stained with brilliant blue. The result showed the size of protein in eluate 6 to be of the order of 24 kD as indicated by an arrow and the protein from eluate 10 to be of the order of 17 kD (B). These data were further corroborated by Western blotting using the antibody to whole caspase-3 (C). Kidney International 2005 68, 2050-2067DOI: (10.1111/j.1523-1755.2005.00662.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 7 Localization of active caspase-3 protein and extracellular matrix deposition. Active caspase-3-positive cells were showed in the glomerulus (A), tubular area (B), expanded interstitial area (C), and tubular lumen (D, arrows) at ×400 magnification. The positive stained area of Sirius Red staining presented a pink color under white light (E) and was strongly birefringent under polarized light (F) at ×200 magnification. Kidney International 2005 68, 2050-2067DOI: (10.1111/j.1523-1755.2005.00662.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 8 Changes of Sirius Red staining (A) and tubulointerstitial damage (B) in different experiment groups. Data are expressed as mean ± SEM (N = 4 to 6). *P < 0.05; **P < 0.01. Abbreviations are: control, sham-operated; UN, unilateral nephrectomy; I/R, ischemia/reperfusion; CsA cyclosporine A; Tac, tacrolimus; Rap, rapamycin; MMF, mycophenolate mofetil. Kidney International 2005 68, 2050-2067DOI: (10.1111/j.1523-1755.2005.00662.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 9 Changes of serum creatinine (A) and urinary protein (B) in different experiment groups. Data are expressed as mean ± SEM (N = 4 to 6). *P < 0.05; **P < 0.01. Abbreviations are: control, sham-operated; UN, unilateral nephrectomy; I/R, ischemia/reperfusion; CsA, cyclosporine A; Tac, tacrolimus; Rap, rapamycin; MMF, mycophenolate mofetil. Kidney International 2005 68, 2050-2067DOI: (10.1111/j.1523-1755.2005.00662.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 10 Correlation between endothelin-1 (ED1+) cells, 24 kD caspase-3 protein or activity and other parameters. (A) ED1+ cells vs. the protein expression of 24 kD caspase-3. (B) ED1+ cells vs. caspase-3 activity. (C) ED1+ cells vs. serum creatinine and urinary protein. (D) 24 kD caspase-3 protein vs. serum creatinine and urinary portiein. (E) ED1+ cells vs. tubulointerstitial damage and Sirus Red staining. (F) 24 kD caspase-3 protein vs. tubulointerstitial damage and Sirus Red staining in the kidneys of various groups. Kidney International 2005 68, 2050-2067DOI: (10.1111/j.1523-1755.2005.00662.x) Copyright © 2005 International Society of Nephrology Terms and Conditions